🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Corbus Pharmaceuticals Holdings, Inc.

Corbus Pharmaceuticals Holdings, Inc. logo
Market Cap: Low
Employees: Lowest

lenabasum, CRB-601, CRB-602

Corbus Pharmaceuticals Holdings, Inc., is a biopharmaceutical company focused on immune modulators for immuno-oncology and fibrosis diseases, developing products like lenabasum and monoclonal antibodies for cancer and fibrosis.

Tags: biopharmaceutical, cancer treatment, cannabinoid receptors, fibrosis, immune modulators, immuno-oncology, metabolic disorders

Symbol: CRBP

Recent Price: $12.08

Industry: Biotechnology

CEO: Dr. Yuval Cohen Ph.D.

Sector: Healthcare

Employees: 19

Address: 500 River Ridge Drive, Norwood, MA 02062

Phone: 617 963 0100

Leadership

  • Alan Holmer, Chairman of the Board
  • Yuval Cohen, Ph.D., Chief Executive Officer, Director
  • Anne Altmeyer, Ph.D., Director
  • Yong Ben, M.D., MBA, Director
  • Rachelle Jacques, Director
  • John Jenkins, M.D., Director
  • Pete Salzmann, M.D., MBA, Director
  • Winston Kung, MBA, Director
  • Dr. Dominic Smethurst, MA MRCP, Chief Medical Officer
  • Sean Moran, CPA, MBA, Chief Financial Officer
  • Christina Bertsch, VP of Human Resources
  • Dr. Dominic Smethurst, Chief Medical Officer

Last updated: 2024-12-31